CNCR vs. CANC

Last updated Jun 24, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and CANC (Tema Oncology ETF) are both Health & Biotech Equities funds. CNCR is passively managed, while CANC is actively managed. CNCR charges 0.79%/yr vs 0.75%/yr for CANC.

Performance

CNCR vs. CANC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and Tema Oncology ETF (CANC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CANC

• 1D: 1.64%
• 1M: 1.56%
• YTD: 11.49%
• 6M: 9.19%
• 1Y: 56.88%
• 3Y*: 132.65%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. CANC - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
CANC Tema Oncology ETF	8.83%

CNCR vs. CANC - Sectors Allocation Comparison

Sectors	CNCR	CANC
Healthcare	96.6%	100.0%
Financial Services	3.3%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

CNCR vs. CANC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

CANC

CANC Risk / Return Rank: 85
CANC Sharpe Ratio Rank: 85
CANC Sortino Ratio Rank: 86
CANC Omega Ratio Rank: 74
CANC Calmar Ratio Rank: 93
CANC Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. CANC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CNCR	CANC	Difference
Sharpe ratio: Return per unit of total volatility	—	2.52	—
Sortino ratio: Return per unit of downside risk	—	3.54	—
Omega ratio: Gain probability vs. loss probability	—	1.40	—
Calmar ratio: Return relative to maximum drawdown	—	6.15	—
Martin ratio: Return relative to average drawdown	—	16.71	—

Drawdowns

CNCR vs. CANC - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for CNCR and CANC.

Drawdown Indicators

	CNCR	CANC	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-97.53%	+97.53%
Max Drawdown (1Y) Largest decline over 1 year	—	-9.30%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-30.27%	—
Current Drawdown Current decline from peak	0.00%	-53.78%	+53.78%
Average Drawdown Average peak-to-trough decline	0.00%	-72.94%	+72.94%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	3.41%	—

Volatility

Volatility by Period

	CNCR	CANC	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	6.60%	—
Volatility (6M) Calculated over the trailing 6-month period	—	16.94%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	22.72%	-22.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	278.65%	-278.65%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	278.65%	-278.65%

CNCR vs. CANC - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is higher than CANC's 0.75% expense ratio.

Dividends

CNCR vs. CANC - Dividend Comparison

CNCR has not paid dividends to shareholders, while CANC's dividend yield for the trailing twelve months is around 0.05%.

Position	TTM	2025	2024	2023
CANC Tema Oncology ETF	0.05%	0.06%	3.00%	0.56%
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Which ETF is better, CNCR or CANC?

On fees, CANC is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or CANC?

CANC is cheaper with a 0.75% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, CNCR or CANC?

CANC has the higher dividend yield at 0.05%, compared with 0.00% for CNCR.

What is the main difference between CNCR and CANC?

They also come from different issuers: Exchange Traded Concepts and Tema. Their fees differ too: 0.79% for CNCR and 0.75% for CANC.